Las Vegas, NVNCT06516653Now EnrollingIRB Ready

End Stage Renal Disease Clinical Trial in Las Vegas, NV

Access cutting-edge end stage renal disease treatment through this clinical trial at a research site in Las Vegas. Study-provided care at no cost to qualified participants.

Sponsored by Laminate Medical Technologies

Quick Self-Assessment

See if you qualify for this Las Vegas location

Preparing your pre-screening questions…

Expert Care in Las Vegas

Access end stage renal disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related end stage renal disease treatment provided free

Apply for This Las Vegas Location

Check if you qualify for this end stage renal disease clinical trial in Las Vegas, NV

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Las Vegas

    Convenient for NV residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Las Vegas site if eligible
  4. 4Begin participation

About This End Stage Renal Disease Study in Las Vegas

VasQ is an external support implant for arteriovenous fistulas created for dialysis access. This is a postmarket surveillance, prospective, multi-center, randomized, controlled, open label trial enrolling 300 patients randomized into two study arms: * Treatment arm: End to side fistula supported with VasQ * Control: Standard of care end to side fistula

Sponsor: Laminate Medical Technologies

Who Can Participate

Inclusion Criteria

Patients who are candidates for the creation of a new radiocephalic or brachiocephalic end-to-side surgical AV fistula for dialysis access (per VasQ IFU and investigator clinical judgment) and consent to take part in the study.
Male and non-pregnant female participants.
Age 18-80 years
Patients willing and able (physically and geographically) to attend follow up visits over a period of 12 months.

Exclusion Criteria

Index procedure being a revision surgery of an existing fistula.
Significantly stenotic target vein on the side of surgery (≥50%) as diagnosed on preoperative ultrasound. (Scan should include the full length of the expected fistula outflow, starting at the planned anastomosis site)
Unusual anatomy or vessel dimensions (observed on pre-operative ultrasound or intraoperatively) and which preclude adequate fit of the VasQ.
Known central venous stenosis or obstruction on the side of surgery.
Pre-existing stents or stent grafts in the access circuit.
Planned subsequent fistula superficialization procedure.
Known coagulation disorder.
Known allergy to nitinol.
Expected kidney transplant within 12 months of enrollment.
Inability to give consent and/or comply with the study follow up schedule.
Insufficient or borderline life expectancy to allow for completion of study procedures and follow-up (12 Months).
Participation in another interventional study that in the judgment of the investigator could confound study results.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Las Vegas?

Yes, this clinical trial (NCT06516653) has an active research site in Las Vegas, NV that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

End Stage Renal Disease Treatment Options in Las Vegas, NV

If you're searching for end stage renal disease treatment options in Las Vegas, NV, this clinical trial (NCT06516653) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Las Vegas research site is actively enrolling participants for this clinical trial. You'll receive care from experienced end stage renal disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all end stage renal disease clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in Las Vegas, NV

See all ankylosing spondylitis clinical trials recruiting in Las Vegas — not just this study.

Browse Ankylosing Spondylitis Trials in Las Vegas →

Browse More Trials by Condition

Ankylosing Spondylitis TrialsChronic Kidney Disease TrialsAll Conditions →

Ready to Join in Las Vegas?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Las Vegas, NV